` 208340 (PharmAbcine Inc) vs KOSPI 200 Comparison - Alpha Spread

P
208340
vs
K
KOSPI 200

Over the past 12 months, PharmAbcine Inc has underperformed KOSPI 200, delivering a return of 0% compared to KOSPI 200's +53% growth.

Stocks Performance
208340 vs KOSPI 200

Loading...
208340
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
208340 vs KOSPI 200

Loading...
208340
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
208340 vs KOSPI 200

Loading...
208340
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
PharmAbcine Inc vs Peers

KOSPI 200
208340
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

PharmAbcine Inc
Glance View

Market Cap
9.2B KRW
Industry
Biotechnology

PharmAbcine Inc. engages in the development of human therapeutic monoclonal antibody (mAb) for the treatment of cancer and inflammatory diseases. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2018-11-21. The firm researching and developing antibody therapeutics to provide patients with the antibodies needed to cure the disease. The Company’s major products include tanibirumab used for cancer treatment, among others. The firm also carries out technology transfer about its pipelines with domestic and overseas pharmaceutical companies.

Intrinsic Value
Not Available
P
Back to Top